Overview

Bethanechol for Eosinophilic Esophagitis

Status:
Terminated

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

The primary goals of this study are to ease the symptoms of patients with Eosinophilic Esophagitis (EoE) and to test the effectiveness of the drug bethanechol in relieving those symptoms.

Phase:

Phase 2

Details

Lead Sponsor:

University of Iowa

Treatments:

Bethanechol